X-linked recessive ocular albinism
Learn about X-linked recessive ocular albinism, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: OA1; Ocular albinism type 1; Ocular albinism, Nettleship-Falls type; XLOA
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis. Ask the treating doctor about these.
What it is
From: Orphanet
X-linked recessive ocular albinism (XLOA) is a rare disorder characterized by ocular hypopigmentation, foveal hypoplasia, nystagmus, photodysphoria, and reduced visual acuity in males.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Abnormal pupil morphology · Very frequent (99-80%)
- An abnormality of the pupil.
- Astigmatism · Very frequent (99-80%)
- A type of refraction error associated with abnormal curvatures on the anterior and/or posterior surface of the cornea.
- Iris hypopigmentation · Very frequent (99-80%)
- An abnormal reduction in the amount of pigmentation of the iris.
- Nystagmus · Very frequent (99-80%)
- Rhythmic, involuntary oscillations of one or both eyes related to abnormality in fixation, conjugate gaze, or vestibular mechanisms.
- Ocular albinism · Very frequent (99-80%)
- An abnormal reduction in the amount of pigmentation (reduced or absent) of the iris and retina.
- Photophobia · Very frequent (99-80%)
- Excessive sensitivity to light with the sensation of discomfort or pain in the eyes due to exposure to bright light.
- Abnormal macular morphology · Frequent (79-30%)
- A structural abnormality of the macula, a region that, in a clinical context, is typically used to describe the central part of the retina within the vascular arcades.
- Freckling · Frequent (79-30%)
- The presence of an increased number of freckles, small circular spots on the skin that are darker than the surrounding skin because of deposits of melanin.
- Hypoplasia of the fovea · Frequent (79-30%)
- Underdevelopment of the fovea centralis.
- Strabismus · Frequent (79-30%)
- A misalignment of the eyes so that the visual axes deviate from bifoveal fixation. The classification of strabismus may be based on a number of features including the relative position of the eyes, whether the deviation is latent or manifest, intermittent or constant, concomitant or otherwise and according to the age of onset and the relevance of any associated refractive error.
- Giant melanosomes in melanocytes · Occasional (29-5%)
- The presence of large spherical melanosomes (1 to 6 micrometer in diameter) in the cytoplasm of melanocytes.
- Myopia · Occasional (29-5%)
- An abnormality of refraction characterized by the ability to see objects nearby clearly, while objects in the distance appear blurry.
- Neoplasm of the skin · Occasional (29-5%)
- A tumor (abnormal growth of tissue) of the skin.
- Visual impairment · Occasional (29-5%)
- Visual impairment (or vision impairment) is vision loss (of a person) to such a degree as to qualify as an additional support need through a significant limitation of visual capability resulting from either disease, trauma, or congenital or degenerative conditions that cannot be corrected by conventional means, such as refractive correction, medication, or surgery.
When it may begin
From: Orphanet
Infancy; Neonatal
Inheritance in the source
From: Orphanet
X-linked recessive
Frequency and the population described
From: Orphanet
Prevalence at birth: 1-9 / 1 000 000; Europe; Value and class. Point prevalence: 1-9 / 1 000 000; Europe; Class only. Prevalence at birth: 1-9 / 1 000 000; Denmark; Value and class. Point prevalence: 1-9 / 1 000 000; Denmark; Class only.
Understanding the inheritance label
From: MedlinePlus Genetics
An X-linked recessive pattern involves a gene on the X chromosome. The number of X chromosomes and the particular genetic change influence how a condition is expressed. A genetic counsellor should interpret the result and the family history before discussing risks for relatives or future pregnancies.
Which doctor should you see?
The suggested department for discussing X-linked recessive ocular albinism is Ophthalmology, with a ophthalmologist as the relevant type of clinician. Ophthalmologist; paediatric services for children as appropriate.
Additional services that may be relevant, depending on the findings, include: Clinical Genetics.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Which part of the eye or visual pathway is affected?
- What change in vision requires immediate contact with the eye service?
- What are the aims and alternatives of any proposed eye treatment?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for X-linked recessive ocular albinism. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by an ophthalmologist. Every profile shows the doctor’s registration and what has been checked.
All ophthalmology conditions →
Sources
- Orphanet — X-linked recessive ocular albinism — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- MedlinePlus Genetics — inheritance patterns — Public-domain Genetics education
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-2480.